In breast cancer bone metastasis, IL-1β from tumor cells and the microenvironment can inhibit primary tumor growth by impairing the infiltration of innate immune cells with potential anti-cancer functions, while simultaneously promoting enhanced tumor cell migration and osteolytic metastases [103]. This evidence concerns the gene IL1B and breast carcinoma.